dc.creatorDourado, Maria Inês Costa
dc.creatorCunha, Sergio
dc.creatorTeixeira, Maria da Glória Lima Cruz
dc.creatorFarrington, C. Paddy
dc.creatorMelo, Ailton de Souza
dc.creatorLucena, Rita de Cássia Saldanha de
dc.creatorBarreto, Mauricio Lima
dc.creatorDourado, Maria Inês Costa
dc.creatorCunha, Sergio
dc.creatorTeixeira, Maria da Glória Lima Cruz
dc.creatorFarrington, C. Paddy
dc.creatorMelo, Ailton de Souza
dc.creatorLucena, Rita de Cássia Saldanha de
dc.creatorBarreto, Mauricio Lima
dc.date.accessioned2013-07-29T13:16:56Z
dc.date.accessioned2022-10-07T18:00:27Z
dc.date.available2013-07-29T13:16:56Z
dc.date.available2022-10-07T18:00:27Z
dc.date.created2013-07-29T13:16:56Z
dc.date.issued2000
dc.identifier0002-9262
dc.identifierhttp://www.repositorio.ufba.br/ri/handle/ri/12325
dc.identifierv. 151, n. 5
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4010910
dc.description.abstractA mass immunization campaign with a Urabe-containing measles-mumps-rubella vaccine was carried out in 1997 in the city of Salvador, northeastern Brazil, with a target population of children aged 1-11 years. There was an outbreak of aseptic meningitis following the mass campaign. Cases of aseptic meningitis were ascertained through data collected from the records of children admitted to the local referral hospital for infectious diseases between March and October of 1997, using previously defined eligibility criteria. Vaccination histories were obtained through home visits or telephone calls. Eighty-seven cases fulfilled the study criteria. Of those, 58 cases were diagnosed after the vaccination campaign. An elevated risk of aseptic meningitis was observed 3 weeks after Brazil's national vaccination day compared with the risk in the prevaccination period (relative risk = 14.3; 95% confidence interval: 7.9, 25.7). This result was confirmed by a case series analysis (relative risk = 30.4; 95% confidence interval: 11.5, 80.8). The estimated risk of aseptic meningitis was 1 in 14,000 doses. This study confirms a link between measles-mumps-rubella vaccination and aseptic meningitis. The authors discuss the implications of this for the organization and planning of mass immunization campaigns. Am J Epidemiol 2000;151:524-30.
dc.languageen
dc.publisherAmerican Journal of Epidemiology
dc.sourcehttp://aje-oxfordjournals-org.ez10.periodicos.capes.gov.br/content/151/5/524.full.pdf+html
dc.subjectdisease outbreaks
dc.subjectmeningitis
dc.subjectaseptic
dc.subjectmumps vaccine
dc.subjectproduct surveillance
dc.subjectpostmarketing
dc.subjectvaccines
dc.titleOutbreak of Aseptic Meningitis associated with Mass Vaccination with a Urabe-containing Measles-Mumps-Rubella Vaccine
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución